Health
Altering balance of fibroblasts could prevent spread of colorectal cancer – Drug Target Review
Researchers found colorectal cancer-associated fibroblasts can be altered with a gremlin 1-neutralising antibody or overexpressing meflin.
Posted: 1 February 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have found that colorectal cancer-associated fibroblasts can be altered using a gremlin 1-neutralising antibody or by overexpressing meflin.
Researchers have revealed that colorectal cancer tissues contain at least two types of fibroblasts – cancer-promoting fibroblasts and cancer-restraining fibroblasts. The team, from Nagoya University, Japan, found that the balance between the two is largely involved in…
-
Noosa News23 hours agoAbusive bus driver fired by council loses appeal
-
General19 hours agoIran’s currency at record low as tensions run high
-
General18 hours agoLabor to pledge $2.3 billion to subsidise home batteries
-
Noosa News23 hours agoHundreds pack neighbourhood for no-reserve auction of ready-made charity home